US probes Germany's drug pricing policies, opens door to tariffs
Published on: June 20, 2026, 1:07 a.m. | Source: The Economic Times
The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US to shoulder a disproportionate share of global drug development costs. This investigation, under Section 301, could lead to new tariffs on Germany. Officials cite concerns that German policies suppress prices for innovative medicines, impacting research funding and potentially affecting American patients.
